Concurrent Analytical Inc

Description

Nanopartz is a division of Concurrent Analytical Inc. (Concana, www.concana.com). Whereas the mission of Concana is to develop its patent pending Ramanprobes technology to revolutionize point-of-care diagnostics in personal medicine, the mission of Nanopartz is to commercialize many of the technologies developed through Concana that have wide ranging applications. These technologies are specifically focused on newly patented or proprietary technologies in nanomaterials, nanoparticles, and nanostructures. So for instance, whereas the nanorod technology was originally developed for use in enhancing the Extrinsic Raman Label technology developed in Concana, nanorods have a tremendous value in photothermal cancer therapy as well. Nanopartz horizontally markets these products to a wide range of applications. Directed Bioflux (www.dbflux.com), like Nanopartz is also a division of Concana and is another entity whose purpose is to commercialize many of the technologies developed through Concana. However, Directed Bioflux is specifically focused on newly patented or proprietary technologies that reduce incubation times in heterogeneous immunoassays. These technologies will reduce total assay times in ELISA, fluorescence, as well as any other diagnostic that requires a reduction in mass transport. For its current product line, Nanopartz utilizes patent pending and proprietary technologies developed in-house, as well as exclusive licenses to patent pending technologies developed at...

Fact sheet

Companies nearby